TRF has showed the anti-cancer biologic function and also found to decrease the levels of IL-6, IL-8 and VEGF related to angiogenic in HUVEC and 4T1 mouse mammary cancer cells[49]. This evidence concerns the gene CXCL8 and breast cancer.